Asbestosis
Clinical Trials
Asbestosis clinical trials are medical research involving volunteer participants, aimed at helping people live better lives. By being able to work with volunteers, doctors can better diagnose, prevent, and treat asbestosis. Several clinical trials are mandatory before determining the safety and efficiency of a new medication, procedure, or device.
Why should you take part in clinical trials?
- Participating patients can access new drugs, surgical and radiologic procedures, devices, or preventive care.
- Participation and access to new treatments can make an important difference for patients diagnosed with serious forms of asbestosis.
Recruiting clinical trials for asbestosis:
- A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells (registered in 2016).
- DIAPHRAGM: Diagnostic and prognostic biomarkers in the rational assessment of mesothelioma (registered in 2013).
- The observational study by CT on technique and diagnostic criteria of the Pneumoconiosis (registered in 2014).
- Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure (registered in 2012).
Mesothelioma
Clinical Trials
Mesothelioma clinical trials help researchers identify what treatments work best. In clinical trials, doctors establish how effective new drugs and therapies are. Being such a rare cancer, the treatment options for mesothelioma have been few. While new treatments are developed, patients are given access to these medications.
Why should you take part in clinical trials?
- Trials offer access to treatments that are not approved yet by FDA such as gene therapy or immunotherapy.
- Patients choose in what trial to take part.
- In a clinical trial, patients have access to more specialized care and closer monitoring.
Recruiting clinical trials for mesothelioma:
- A Phase II Trial of R435 (Bevacizumab) in chemotherapy-naive and inoperable malignant pleural mesothelioma patients (registered in 2016).
- Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma (registered in 2016).
- Staging Procedures to Diagnose Malignant Pleural Mesothelioma (registered in 2015).
- Safety Study of MGD009 in B7-H3-expressing Tumors (registered in 2015).
- Zoledronic acid in the management of malignant pleural mesothelioma - a feasibility study - ZOL-A trial(registered in 2016)